Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 23-Apr-24 5:03 PM View:  | Alloway Paul See Remarks | Q32 Bio Inc. (QTTB) | 25-Mar-24 | Private Sale (Planned) | 268 | $24.21 | $6,488.28 | (9%) 2.86K to 2.6K | |
| 27-Mar-24 4:15 PM View: | Michaud Charles Jr See Remarks | Q32 Bio Inc. (QTTB) | 25-Mar-24 | Option Exercise | 6,448 | -- | -- | 56% 11.6K to 18.05K | |
| 23-Apr-24 5:00 PM View: | Michaud Charles Jr See Remarks | Q32 Bio Inc. (QTTB) | 25-Mar-24 | Private Sale (Planned) | 75 | $24.20 | $1,815.00 | (7%) 1.0K to 0.93K | |
| 27-Mar-24 4:15 PM View: | Alloway Paul See Remarks | Q32 Bio Inc. (QTTB) | 25-Mar-24 | Option Exercise | 23,530 | -- | -- | 84% 28.04K to 51.57K | |
| 15-Feb-24 4:33 PM View: | Tzianabos Arthur Director | Q32 Bio Inc. (QTTB) | 09-Jan-24 | Planned Option Sale | 13,037 | $0.57 | $7,445.43 | (9%) 141.81K to 128.78K | |
| 05-Jan-24 5:49 PM View: | Michaud Charles Jr See Remarks | Q32 Bio Inc. (QTTB) | 03-Jan-24 | Sale (Planned) | 1,708 | $0.57 | $975.27 | (13%) 13.31K to 11.6K | |
| 05-Jan-24 5:54 PM View: | Alloway Paul See Remarks | Q32 Bio Inc. (QTTB) | 03-Jan-24 | Sale (Planned) | 7,280 | $0.57 | $4,120.48 | (21%) 35.32K to 28.04K | |
| 03-Jan-24 4:15 PM View: | Alloway Paul See Remarks | Q32 Bio Inc. (QTTB) | 01-Jan-24 | Option Exercise | 18,610 | -- | -- | 111% 16.71K to 35.32K | |
| 15-Feb-24 4:33 PM View: | Tzianabos Arthur Director | Q32 Bio Inc. (QTTB) | 01-Jan-24 | Option Exercise | 33,420 | -- | -- | 31% 108.39K to 141.81K | |
| 03-Jan-24 4:15 PM View: | Michaud Charles Jr See Remarks | Q32 Bio Inc. (QTTB) | 01-Jan-24 | Option Exercise | 4,240 | -- | -- | 47% 9.07K to 13.31K | |
| 08-Sep-23 4:44 PM View: | Seymour Albert See remarks Director | Q32 Bio Inc. (QTTB) | 06-Sep-23 | Option Exercise | 4,620 | -- | -- | 3% 147.7K to 152.32K | |
| 08-Sep-23 4:44 PM View: | Seymour Albert See remarks Director | Q32 Bio Inc. (QTTB) | 06-Sep-23 | Planned Option Sale | 1,448 | $1.15 | $1,665.49 | (< 1%) 152.32K to 150.87K | |
| 07-Aug-23 9:39 PM View: | Jordan Julie Chief Medical Officer | Q32 Bio Inc. (QTTB) | 03-Aug-23 | Option Exercise | 6,579 | -- | -- | 238% 2.77K to 9.35K | |
| 07-Aug-23 9:39 PM View: | Jordan Julie Chief Medical Officer | Q32 Bio Inc. (QTTB) | 03-Aug-23 | Planned Option Sale | 545 | $1.39 | $757.55 | (7%) 8.04K to 7.5K | |
| 07-Aug-23 9:39 PM View: | Jordan Julie Chief Medical Officer | Q32 Bio Inc. (QTTB) | 03-Aug-23 | Option Sale | 1,308 | $1.39 | $1,818.12 | (14%) 9.35K to 8.04K | |
| 04-Aug-23 4:08 PM View: | Jordan Julie Chief Medical Officer | Q32 Bio Inc. (QTTB) | 02-Aug-23 | Planned Option Sale | 99 | $1.31 | $129.69 | (3%) 2.87K to 2.77K | |
| 04-Aug-23 4:08 PM View: | Jordan Julie Chief Medical Officer | Q32 Bio Inc. (QTTB) | 02-Aug-23 | Option Exercise | 350 | -- | -- | 14% 2.52K to 2.87K | |
| 06-Mar-23 4:05 PM View: | Alloway Paul See Remarks | Q32 Bio Inc. (QTTB) | 02-Mar-23 | Sale (Planned) | 10,965 | $1.45 | $15,863.10 | (40%) 27.67K to 16.71K | |
| 11-Jan-23 4:05 PM View: | Smith W Bradford See Remarks | Q32 Bio Inc. (QTTB) | 09-Jan-23 | Sale (Planned) | 3,729 | $1.39 | $5,187.78 | (21%) 17.95K to 14.22K | |
| 11-Jan-23 4:05 PM View: | Alloway Paul See Remarks | Q32 Bio Inc. (QTTB) | 09-Jan-23 | Sale (Planned) | 3,090 | $1.39 | $4,296.03 | (13%) 23.19K to 20.1K | |
| 11-Jan-23 4:05 PM View: | Blum Michael Lee Chief Commercial Officer | Q32 Bio Inc. (QTTB) | 09-Jan-23 | Sale (Planned) | 2,454 | $1.39 | $3,412.04 | (15%) 15.99K to 13.54K | |
| 11-Jan-23 4:05 PM View: | Seymour Albert See remarks Director | Q32 Bio Inc. (QTTB) | 09-Jan-23 | Sale (Planned) | 3,620 | $1.39 | $5,033.25 | (2%) 146.79K to 143.17K | |
| 11-Jan-23 4:05 PM View: | Tzianabos Arthur Director | Q32 Bio Inc. (QTTB) | 09-Jan-23 | Sale (Planned) | 10,616 | $1.39 | $14,761.50 | (9%) 119.01K to 108.39K | |
| 04-Jan-23 4:32 PM View: | Alloway Paul See Remarks | Q32 Bio Inc. (QTTB) | 01-Jan-23 | Option Exercise | 9,570 | -- | -- | 70% 13.62K to 23.19K | |
| 04-Jan-23 4:37 PM View: | Blum Michael Lee Chief Commercial Officer | Q32 Bio Inc. (QTTB) | 01-Jan-23 | Option Exercise | 7,590 | -- | -- | 90% 8.4K to 15.99K | |
| 04-Jan-23 10:00 PM View: | Seymour Albert See remarks Director | Q32 Bio Inc. (QTTB) | 01-Jan-23 | Option Exercise | 11,220 | -- | -- | 8% 135.57K to 146.79K | |
| 04-Jan-23 4:36 PM View: | Tzianabos Arthur Director | Q32 Bio Inc. (QTTB) | 01-Jan-23 | Option Exercise | 33,000 | -- | -- | 38% 86.01K to 119.01K | |
| 04-Jan-23 4:34 PM View: | Smith W Bradford See Remarks | Q32 Bio Inc. (QTTB) | 01-Jan-23 | Option Exercise | 13,530 | -- | -- | 306% 4.42K to 17.95K | |
| 12-Jan-22 4:05 PM View: | Smith W Bradford CFO & Treasurer | Q32 Bio Inc. (QTTB) | 05-Jan-22 | Market Option Sale (Planned) | 2,182 | $3.78 | $8,248.40 | (33%) 6.6K to 4.42K | |
| 12-Jan-22 4:05 PM View: | Kelly Timothy P Chief Operating Officer | Q32 Bio Inc. (QTTB) | 05-Jan-22 | Market Option Sale (Planned) | 1,406 | $3.78 | $5,314.82 | (39%) 3.63K to 2.22K | |
| 12-Jan-22 4:05 PM View: | Tzianabos Arthur President & CEO Director | Q32 Bio Inc. (QTTB) | 05-Jan-22 | Market Option Sale (Planned) | 5,354 | $3.78 | $20,239.20 | (6%) 91.36K to 86.01K | |
| 12-Jan-22 4:05 PM View: | Seymour Albert Chief Scientific Officer | Q32 Bio Inc. (QTTB) | 05-Jan-22 | Market Option Sale (Planned) | 1,661 | $3.78 | $6,278.75 | (1%) 133.31K to 131.65K | |
| 12-Jan-22 4:05 PM View: | Cohn Gabriel Chief Medical Officer | Q32 Bio Inc. (QTTB) | 05-Jan-22 | Market Option Sale (Planned) | 1,661 | $3.78 | $6,278.75 | (39%) 4.29K to 2.63K | |
| 12-Jan-22 4:05 PM View: | Tzianabos Arthur President & CEO Director | Q32 Bio Inc. (QTTB) | 01-Jan-22 | Option Exercise | 13,860 | -- | -- | 18% 77.5K to 91.36K | |
| 12-Jan-22 4:05 PM View: | Smith W Bradford CFO & Treasurer | Q32 Bio Inc. (QTTB) | 01-Jan-22 | Option Exercise | 6,600 | -- | -- | 100% 0 to 6.6K | |
| 12-Jan-22 4:05 PM View: | Cohn Gabriel Chief Medical Officer | Q32 Bio Inc. (QTTB) | 01-Jan-22 | Option Exercise | 4,290 | -- | -- | 100% 0 to 4.29K | |
| 12-Jan-22 4:05 PM View: | Seymour Albert Chief Scientific Officer | Q32 Bio Inc. (QTTB) | 01-Jan-22 | Option Exercise | 4,290 | -- | -- | 3% 129.02K to 133.31K | |
| 12-Jan-22 4:05 PM View: | Kelly Timothy P Chief Operating Officer | Q32 Bio Inc. (QTTB) | 01-Jan-22 | Option Exercise | 3,630 | -- | -- | 100% 0 to 3.63K | |
| 08-Sep-21 4:10 PM View: | Kelly Timothy P See Remarks. | Q32 Bio Inc. (QTTB) | 03-Sep-21 | Market Sale (Planned) | 54 | $7.70 | $415.80 | (100%) 54 to 0 | |
| 09-Feb-21 4:22 PM View: | Smith W Bradford CFO & Treasurer | Q32 Bio Inc. (QTTB) | 08-Feb-21 | Option Exercise | 13,500 | $0.64 | $8,640.00 | 100% 0 to 13.5K | |
| 09-Feb-21 4:22 PM View: | Smith W Bradford CFO & Treasurer | Q32 Bio Inc. (QTTB) | 08-Feb-21 | Market Option Sale (Planned) | 13,500 | $14.25 | $192,425.00 | (100%) 13.5K to 0 | |
| 05-Feb-21 6:31 AM View: | Kelly Timothy P See Remarks | Q32 Bio Inc. (QTTB) | 02-Feb-21 | Market Option Sale (Planned) | 500 | $13.00 | $6,500.00 | (100%) 0.5K to 0 | |
| 05-Feb-21 6:31 AM View: | Kelly Timothy P See Remarks | Q32 Bio Inc. (QTTB) | 02-Feb-21 | Option Exercise | 500 | $6.63 | $3,315.70 | 100% 0 to 0.5K | |
| 03-Feb-21 4:05 PM View: | Kelly Timothy P See Remarks | Q32 Bio Inc. (QTTB) | 01-Feb-21 | Option Exercise | 4,000 | $4.76 | $19,052.20 | 100% 0 to 4.0K | |
| 03-Feb-21 4:05 PM View: | Kelly Timothy P See Remarks | Q32 Bio Inc. (QTTB) | 01-Feb-21 | Market Option Sale (Planned) | 4,000 | $12.36 | $49,460.00 | (100%) 4.0K to 0 | |
| 14-Jan-21 4:05 PM View: | Kelly Timothy P See Remarks | Q32 Bio Inc. (QTTB) | 12-Jan-21 | Option Exercise | 500 | $6.63 | $3,315.70 | 100% 0 to 0.5K | |
| 14-Jan-21 4:05 PM View: | Kelly Timothy P See Remarks | Q32 Bio Inc. (QTTB) | 12-Jan-21 | Market Option Sale (Planned) | 500 | $13.00 | $6,500.00 | (100%) 0.5K to 0 | |
| 08-Jan-21 4:05 PM View: | Seymour Albert Chief Scientific Officer | Q32 Bio Inc. (QTTB) | 07-Jan-21 | Market Sale (Planned) | 5,103 | $12.05 | $61,469.20 | (4%) 134.12K to 129.02K | (4%) |
| 08-Jan-21 4:05 PM View: | Seymour Albert Chief Scientific Officer | Q32 Bio Inc. (QTTB) | 06-Jan-21 | Market Sale (Planned) | 9,897 | $12.06 | $119,395.00 | (7%) 144.02K to 134.12K | (4%) |
| 07-Jan-21 4:05 PM View: | Seymour Albert Chief Scientific Officer | Q32 Bio Inc. (QTTB) | 05-Jan-21 | Market Sale (Planned) | 10,000 | $11.44 | $114,422.00 | (6%) 154.02K to 144.02K | (5%) |
